Xavier Intes Awarded Grant from the National Cancer Institute at the NIH
Dr. Intes has been awarded a two-year, $378K R21 grant from the National Cancer Institute at the NIH. The grant will be used to develop a Multispectral Fluorescence Molecular Tomography (MFMT) tool capable of simultaneous tracking of multiple fluorophores in vivo in small animals. The new technique represents a significant development in the field of biomedical engineering. In particular MFMT will allow to track biological processes in vivo and provide plethora of information on diseases states, and help development of new targeted drugs.